| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. | Director | Common Stock | 5.05K | $2.12K | $0.42 | Mar 28, 2024 | Direct |
| Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19.8K | Oct 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Oct 1, 2024 | 3 | $0 | 4 | Oct 3, 2024 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 28, 2024 | 1 | $22.2K | 4 | Mar 29, 2024 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 4, 2023 | 1 | $0 | 4 | Oct 5, 2023 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 6, 2022 | 2 | $42.9K | 4 | Oct 11, 2022 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 5, 2022 | 1 | $0 | 4 | Oct 7, 2022 | Director |
| OTLK | Outlook Therapeutics, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 24, 2022 | Director |
| OTLK | Outlook Therapeutics, Inc. | Dec 2, 2021 | 1 | $13.9K | 4 | Dec 2, 2021 | Director |
| OTLK | Outlook Therapeutics, Inc. | Oct 5, 2021 | 1 | $0 | 4 | Oct 7, 2021 | Director |